DekaBank Deutsche Girozentrale
SCLN

DekaBank Deutsche Girozentrale’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-27,600
Closed -$364K – 1062
2016
Q2 		$364K Buy
27,600
+5,100
+23% +$66.8K ﹤0.01% 743
2016
Q1 		$218K Sell
22,500
-3,100
-12% -$27.6K ﹤0.01% 837
2015
Q4 		$235K Buy
25,600
+500
+2% +$4.18K ﹤0.01% 835
2015
Q3 		$174K Buy
25,100
+500
+2% +$4.28K ﹤0.01% 892
2015
Q2 		$242K Buy
24,600
+1,000
+4% +$9.11K ﹤0.01% 844
2015
Q1 		$209K Sell
23,600
-4,000
-14% -$31.9K ﹤0.01% 893
2014
Q4 		$239K Sell
27,600
-2,500
-8% -$20.2K ﹤0.01% 829
2014
Q3 		$207K Buy
30,100
+500
+2% +$3K ﹤0.01% 806
2014
Q2 		$156K Sell
29,600
-3,500
-11% -$17K ﹤0.01% 785
2014
Q1 		$151K Buy
33,100
+2,000
+6% +$9.66K ﹤0.01% 756
2013
Q4 		$159K Buy
31,100
+1,000
+3% +$4.81K ﹤0.01% 687
2013
Q3 		$153K Buy
+30,100
New +$168K ﹤0.01% 694

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DekaBank Deutsche Girozentrale's SCLN Position: Q3 2016 in Review

DekaBank Deutsche Girozentrale sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2016, closing a stake of 27,600 shares — an estimated $364K sold.

DekaBank Deutsche Girozentrale first reported a position in SCLN in Q3 2013 and held it in 12 quarters. The position peaked at $364K in Q2 2016. 151 funds tracked by Wall St. Rank hold SCLN as of Q3 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 27,600 Sciclone Pharmaceuticals Inc shares in Q3 2016, an estimated $364K.
  • DekaBank Deutsche Girozentrale first reported a position in Sciclone Pharmaceuticals Inc in Q3 2013 and held it in 12 quarters.
  • DekaBank Deutsche Girozentrale's Sciclone Pharmaceuticals Inc position peaked at $364K in Q2 2016.
  • 151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2016, filed 8 Nov 2016.